Personer, som allerede var inficeret med en eller flere vaccine- relaterede HPV- typer forud for vaccination, var beskyttet imod klinisk sygdom forårsaget af de resterende vaccine- HPV- typer.
Individuals who were already infected with one or more vaccine-related HPV types prior to vaccination were protected from clinical disease caused by the remaining vaccine HPV types.